Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of patients within a decade.
Idiopathic pulmonary…
Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of patients within a decade.
Idiopathic pulmonary…
Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study led by the Hospital del Mar Research Institute and published in Nature Communications, with participation from research…
To encourage scientists to speak up when people misuse science to serve political agendas, biology professor Mark Peifer of the University of North Carolina at Chapel Hill argues that eugenics should be included in college genetics curriculums….
Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could…
Layer Health cofounders Luke Murray, Monica Agrawal, Divya Gopinath, David Sontag, and Steven Horng
Artificial intelligence (AI) is enjoying its moment as the hottest area of venture investment, with more than $100 billion flowing…
The Trump administration’s firing and furloughing of tens of thousands of federal workers and contractors have obviously caused economic hardship for Americans employed in national parks, research labs and dozens of government agencies.
Interior view of Novo Nordisk’s headquarters in Denmark. It is a leading global pharmaceutical … [+]
Americans pay more for prescription drugs than citizens in any other…
Gather Health cofounder and CEO Brent Asplin with patient Karen Sterling in the health group’s Quincy, Mass., office.
Gather Health
After more than a decade as an emergency room doctor, Brent Asplin was fed up. He saw too many patients come in…
Two new studies released in 2025 provide a mixed picture of how well our current antivirals are holding up against H5N1, the highly pathogenic bird flu virus that continues to spill over into mammals and humans. The good news: H5N1 viruses from…